CONDENSED CONSOLIDATING FINANCIAL INFORMATION - Cash Flows (Details) - USD ($) $ in Thousands | 6 Months Ended |
Jul. 30, 2016 | Aug. 01, 2015 |
Condensed Consolidating Statement of Cash Flows | | |
Net cash provided by (used in) operating activities | $ 63,569 | $ 10,964 |
Cash flows from investing activities: | | |
Capital expenditures | (25,749) | (47,350) |
Proceeds from insurance claim | | 1,510 |
Proceeds from sale of property, fixtures and equipment | 7 | 84,066 |
Net cash (used in) provided by investing activities | (25,742) | 38,226 |
Cash flows from financing activities: | | |
Payments on long-term debt and capital lease obligations | (303,258) | (392,183) |
Proceeds from issuance of long-term debt | 263,669 | 370,390 |
Deferred financing costs paid | (495) | |
Cash dividends paid | | (2,004) |
Restricted shares forfeited in lieu of payroll taxes | (120) | (399) |
Proceeds from stock options exercised | | 454 |
Increase (decrease) in book overdraft balances | 2,545 | (13,266) |
Net cash used in financing activities | (37,659) | (37,008) |
Net increase in cash and cash equivalents | 168 | 12,182 |
Cash and cash equivalents at beginning of period | 6,879 | 8,753 |
Cash and cash equivalents at end of period | 7,047 | 20,935 |
Consolidating Eliminations | | |
Condensed Consolidating Statement of Cash Flows | | |
Net cash provided by (used in) operating activities | | (5,621) |
Cash flows from investing activities: | | |
Intercompany investing activity | | 32,693 |
Net cash (used in) provided by investing activities | | 32,693 |
Cash flows from financing activities: | | |
Intercompany financing activity | | (27,072) |
Net cash used in financing activities | | (27,072) |
Parent | Reportable Legal Entities | | |
Condensed Consolidating Statement of Cash Flows | | |
Net cash provided by (used in) operating activities | 120 | 2,403 |
Cash flows from investing activities: | | |
Intercompany investing activity | | (454) |
Net cash (used in) provided by investing activities | | (454) |
Cash flows from financing activities: | | |
Cash dividends paid | | (2,004) |
Restricted shares forfeited in lieu of payroll taxes | (120) | (399) |
Proceeds from stock options exercised | | 454 |
Net cash used in financing activities | (120) | (1,949) |
Cash and cash equivalents at beginning of period | 1 | 1 |
Cash and cash equivalents at end of period | 1 | 1 |
Issuer | Reportable Legal Entities | | |
Condensed Consolidating Statement of Cash Flows | | |
Net cash provided by (used in) operating activities | 47,407 | (24,619) |
Cash flows from investing activities: | | |
Capital expenditures | (11,635) | (37,807) |
Intercompany investing activity | | (32,239) |
Proceeds from sale of property, fixtures and equipment | 7 | 16,344 |
Net cash (used in) provided by investing activities | (11,628) | (53,702) |
Cash flows from financing activities: | | |
Payments on long-term debt and capital lease obligations | (301,300) | (277,965) |
Proceeds from issuance of long-term debt | 263,669 | 370,390 |
Intercompany financing activity | | (2,004) |
Deferred financing costs paid | (495) | |
Increase (decrease) in book overdraft balances | 2,545 | (13,266) |
Net cash used in financing activities | (35,581) | 77,155 |
Net increase in cash and cash equivalents | 198 | (1,166) |
Cash and cash equivalents at beginning of period | 2,822 | 4,209 |
Cash and cash equivalents at end of period | 3,020 | 3,043 |
Guarantor Subsidiaries | Reportable Legal Entities | | |
Condensed Consolidating Statement of Cash Flows | | |
Net cash provided by (used in) operating activities | 16,042 | 38,801 |
Cash flows from investing activities: | | |
Capital expenditures | (14,114) | (9,543) |
Proceeds from insurance claim | | 1,510 |
Proceeds from sale of property, fixtures and equipment | | 67,722 |
Net cash (used in) provided by investing activities | (14,114) | 59,689 |
Cash flows from financing activities: | | |
Payments on long-term debt and capital lease obligations | (1,958) | (114,218) |
Intercompany financing activity | | 29,076 |
Net cash used in financing activities | (1,958) | (85,142) |
Net increase in cash and cash equivalents | (30) | 13,348 |
Cash and cash equivalents at beginning of period | 4,056 | 4,543 |
Cash and cash equivalents at end of period | $ 4,026 | $ 17,891 |